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OBJECTIVEdTo evaluate the phenotype of 15 children with congenital hyperinsulinism
(CHI) and profound hearing loss, known as Homozygous 11p15-p14 Deletion syndrome
(MIM #606528).
RESEARCH DESIGN AND METHODSdProspective clinical follow-up and genetic
analysis by direct sequencing, multiplex ligation-dependent probe ampliﬁcation, and microsa-
tellite markers.
RESULTSdGenetic testing identiﬁed the previous described homozygous deletion in 11p15,
USH1C:c.(90+592)_ABCC8:c.(2694–528)del. Fourteen patients had severe CHI demanding
near-total pancreatectomy. In one patient with mild, transient neonatal hypoglycemia and non-
autoimmune diabetes at age 11 years, no additional mutations were found in HNF1A, HNF4A,
GCK, INS, and INSR. Retinitis pigmentosa was found in two patients aged 9 and 13 years. No
patients had enteropathy or renal tubular defects. Neuromotor development ranged from normal
to severe delay with epilepsy.
CONCLUSIONSdThe phenotype of Homozygous 11p15-p14 Deletion syndrome, or Usher-
CHI syndrome, includes any severity of neonatal-onset CHI and severe, sensorineural hearing
loss. Retinitis pigmentosa and nonautoimmune diabetes may occur in adolescence.
Diabetes Care 36:557–561, 2013
Congenital hyperinsulinism (CHI,MIM #256450) is a heterogeneousdisease with hyperinsulinemic hy-
poglycemia, most frequently caused by
mutations in ABCC8 (1,2). Usher syn-
drome 1C (USH1C, MIM #296904) is
caused by mutations in USH1C (3), a
gene situated next to ABCC8 on chromo-
some 11p15.1. A very rare, homozygous
contiguous gene deletion, including
USHIC and ABCC8, has been described
in three patients, characterized by severe
CHI, deafness, vestibular hypofunction,
severe enteropathy, and renal tubular
dysfunction (MIM #606528) (4,5).
We report on 15 new patients from
eight consanguineous families with the
same homozygous deletion, but with clin-
ical heterogeneity and with manifestations
from b-cells, inner ear, and retina only.
RESEARCH DESIGN AND
METHODSdAmong children with
CHI in Riyadh and London, we identiﬁed
15 patients with severe congenital hearing
loss. USH1C, ABCC8, and KCNJ11 were
analyzed by sequencing and multiplex
ligation-dependent probe ampliﬁcation
(MLPA) (for details, see Supplementary
Figs. 1–4). Patient 3 was analyzed through
two separate blood samples with addi-
tional sequencing of the nonsyndromic
diabetes-related genes HNF1A, HNF4A,
GCK, INS, and INSR. DNA microsatellite
markers were used for haplotype analysis.
Informed consent was obtained.
RESULTSdFifteen patients from eight
apparently unrelated, consanguineous
families in Saudi Arabia and Kuwait
were identiﬁed with deafness and CHI.
Of these, 14 had severe CHI with need of
subtotal pancreatectomy (Table 1). One
patient (patient 3) had mild hypoglyce-
mia only, which was diagnosed at 3
months of age. By 11 years, his HbA1c
level gradually increased to 8.5% (refer-
ence 4.4–6.4%), fasting blood glucose in-
creased to 15 mmol/L, and postprandial
hyperglycemia increased to 13 mmol/L.
Serum insulin was low, 49 mU/L (refer-
ence 72–150 mU/L), blood glucose was
12.6 mmol/L, and 2-h oral glucose toler-
ance test (OGTT) glucose was 16mmol/L.
Autoantibodies were negative, and BMI
was 21.6 kg/m2. No syndromic features
were found and the mother had normal
hearing, giving no clues for inheritance of
syndromic diabetes mutations. The pa-
tient responded to metformin treatment.
Profound hearing loss with absent
brain stem auditory-evoked response
was diagnosed in all patients, with the
exception of one who died early (Table 1).
It is noteworthy that the atypical patient 3
also had severe hearing loss and devel-
oped retinitis pigmentosa at age 13 years.
One other patient had retinal changes
with absent visual-evoked response at
9.5 years. No patients had clinical evidence
of vestibular dysfunction, prolonged
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diarrhea, vomiting, signs of renal tubular
defects, or amino or organic acid in the
urine.
None of the parents or other siblings
had a history of hypoglycemia, diabetes,
hearing loss, dizziness, vision anomalies, or
signs of enteropathy or nephropathy. Pa-
rents had normal HbA1c (5.2–6.0%), fast-
ing blood glucose (4.8–6.7 mmol/L), and
2-h OGTT glucose (4.1–9.3 mmol/L),
except one with 2-h OGTT glucose (12.5
mmol/L), which was explained by severe
obesity (BMI 31 kg/m2).
In all 10 patients with available DNA,
sequence analysis revealed a 122.815-
base pair deletion of USH1C exon 3–28
and ABCC8 exon 1–22, USH1C:c.(90+
592)_ABCC8: c.(2694–528)del. MLPA
analyses conﬁrmed the heterozygous state
of the parents and the homozygous state of
the offspring. In the atypical patient 3, the
homozygous deletion was veriﬁed in two
separate blood samples. No mutations
were found in antagonizing, nonsyndromic
diabetic genes. Microsatellite analysis in
12 parents showed a common ancestral
haplotype. The mutation was calculated
to be introduced in all the families approx-
imately 3.9 generations previously for the
parental generation.
CONCLUSIONSdWe added 15 new
patients to the only three patients already
described with Usher-CHI syndrome and
made a much longer follow-up until 16
years of age. Our data alter the phenotype
description of the syndrome, not only in
terms of a variable degree of hyperinsu-
linism with possibility of conversion to
diabetes in the second decade but also in
the Usher-related manifestations.
The deletion in USH1C-ABCC8 was
exactly the same in all the investigated
patients as in the two previously reported
families (4,5) and calculated to be intro-
duced in all six families studied approxi-
mately 3.9 generations before. Using an
average generation time of 21.28 years
in Saudi Arabia (6), this corresponds
to a mutation age of 85 years.
In 14 patients, the hyperinsulinemic
hypoglycemia was severe with early neo-
natal onset and did not respond to medical
treatment, which is in line with the previous
reports (4,5) and three other patients de-
scribed with ABCC8macrodeletions (7,8).
In contrast, one patient had very mild hy-
poglycemia only with conversion to dia-
betes in puberty, without any clue of
mosaicism, type 1 diabetes, type 2 diabe-
tes, or additional diabetes gene mutations.
A homozygousABCC8 deletion is expected
to result in a completely nonfunctional
b-cell KATP channel (9,10) as in mice
SUR1 knockout (11,12). However,
SUR12/2 and Kir6.22/2 mice have mild,
transient neonatal hyperinsulinism only,
with rapid reversion to glucose intolerance
and loss of insulin secretion in adulthood
because of a lack of ﬁrst-phase and an at-
tenuated second-phase insulin secretion
in response to glucose (11–13). Species
differences include an attenuated b-cell–
amplifying pathway in mice, suggesting
that the amplifying pathway 1) has an im-
portant role in producing severe and per-
sistent hyperinsulinism in the patient with
typical Usher-CHI syndrome and 2) may
be attenuated in the atypical mild patient.
The large USH1C homozygous dele-
tion resulted in profound, congenital sen-
sorineural deafness in all investigated
patients, identical to the effect of reported
USH1C pointmutations (3,14). Progressive
retinitis pigmentosa is seen in USH1C pa-
tients with onset of nyctalopia (night blind-
ness) from 7 to 15 years (15). Retinitis
pigmentosa was diagnosed in two of our
patients only because of young age. In
USH1C, vestibular dysfunction may only
be detected as absence of nystagmus on ca-
loric stimulation (15) and was not detected
in our patients, in contrast to the previous
study (5). The three previously reported
patients with Usher-CHI syndrome also
had severe enteropathy and renal tubular
defects (4,5). Such manifestations were
not seen in our patients and have not
been reported in others with USH1 or
CHI only, neither in USH1C knock-in or
knockout mice nor in SUR1 knockout
mice. It is suggested that the gut and renal
manifestations in the previous reports were
not the result of the homozygous deletion.
In conclusion, the phenotype ofUsher-
CHI syndrome is characterized by Usher 1
manifestations and a heterogeneous CHI
pattern ranging from severe, persistent
CHI to mild and transient hyperinsulinism
with conversion to diabetes in the second
decade.
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